Question

I am a breastfeeding mother and i want to know if it is safe to use BRL-49653? Is BRL-49653 safe for nursing mother and child? Does BRL-49653 extracts into breast milk? Does BRL-49653 has any long term or short term side effects on infants? Can BRL-49653 influence milk supply or can BRL-49653 decrease milk supply in lactating mothers?

BRL-49653 lactation summary

BRL-49653 usage has low risk in breastfeeding
  • DrLact safety Score for BRL-49653 is 3 out of 8 which is considered Low Risk as per our analyses.
  • A safety Score of 3 indicates that usage of BRL-49653 may cause some minor side effects in breastfed baby.
  • Our study of different scientific research indicates that BRL-49653 may cause moderate to no side effects in lactating mother.
  • Most of scientific studies and research papers declaring usage of BRL-49653 low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • While using BRL-49653 We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About BRL-49653 usage in lactation

Tiazolidindion drugs increase the response to insulin.Oral anti-diabetic drugs are useless for treatment of diabetes type 1. For diabetes type 2, diet and exercise are advisable. Breastfeeding helps to lower glucemia level. See section on Maternal diabetes mellitus

Answer by DrLact: About BRL-49653 usage in lactation

No information is available on the clinical use of BRL-49653 during breastfeeding. BRL-49653 is over 99% protein bound in plasma, so it is unlikely to pass into breastmilk in clinically important amounts. The manufacturer recommends avoiding breastfeeding during BRL-49653 use, so pioglitazone might be a better choice of the drugs in this class for nursing mothers.
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.